Eupraxia Pharmaceuticals (EPRX) Non Operating Interest Expenses (2023 - 2024)
Eupraxia Pharmaceuticals' Non Operating Interest Expenses came in at -$137.00 for the quarter ended Dec 31, 2024, compared with -$256,460 a year earlier.
Powered by 
Analysis
Eupraxia Pharmaceuticals (EPRX) Non Operating Interest Expenses (2023 - 2024) Analysis & Trends
For the year ended Dec 31, 2024, Eupraxia Pharmaceuticals' Non Operating Interest Expenses was -$603,573.
- Going back by year, Non Operating Interest Expenses was -$1.17 million in the year ended Dec 31, 2023 and -$982,856 in the year ended Dec 31, 2022.
- The figure for the quarter ended Dec 31, 2024 represents the highest quarterly Non Operating Interest Expenses in data going back to the quarter ended Mar 31, 2023.
- Business Quant data shows EPRX's Non Operating Interest Expenses at -$451.00 (quarter ended Sep 30, 2024), -$281,845 (quarter ended Jun 30, 2024) and -$321,140 (quarter ended Mar 31, 2024) in the three quarters before the quarter ended Dec 31, 2024.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Operating Interest Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 281.00 Mn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | - |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | -462.00 Mn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | -435.00 Mn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 673.00 Mn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 247.00 Mn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | - |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | - |
| 10 | Eupraxia Pharmaceuticals | 363.60 Mn | 362.00 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2024 | -137.00 |
| Sep 30, 2024 | -451.00 |
| Jun 30, 2024 | -281,845.00 |
| Mar 31, 2024 | -321,140.00 |
| Dec 31, 2023 | -256,460.00 |
| Sep 30, 2023 | -320,466.00 |
| Jun 30, 2023 | -301,770.00 |
| Mar 31, 2023 | -291,477.00 |
API Access
Eupraxia Pharmaceuticals Non Operating Interest Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-operating-interest-expenses&ticker=EPRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-operating-interest-expenses", "ticker": "EPRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-operating-interest-expenses&ticker=EPRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();